Devices for Inhaled Medications Market Report

Global and Region Devices for Inhaled Medications Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：205
  • REPORT CODE：GMM1015740
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Devices for Inhaled Medications market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Devices for Inhaled Medicationsmarket, defines the market attractiveness level of Devices for Inhaled Medications market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Devices for Inhaled Medications industry, describes the types of Devices for Inhaled Medications market, the applications of major players and the market size, and deeply analyzes the current situation of the global Devices for Inhaled Medications market and the development prospects and opportunities of Devices for Inhaled Medications industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Devices for Inhaled Medications market in Chapter 13.

    By Player:

    • Catalent, Inc

    • Mantecorp

    • 3M

    • Qualicaps

    • Boehringer Ingelheim

    • Inhalexper

    • Hovione

    • Aerovance

    • MicroDose Therapeutx

    • VertMarkets, Inc

    • GlaxoSmithKline

    • Consort Medical

    • Cipla

    • AstraZeneca

    • Novartis

    • Qualicaps

    • Cambridge Consultants

    • Chiesi

    • Meda

    • Civitas/Alkermes

    • Mannkind

    By Type:

    • Dry Powder Inhalers

    • Metered-Dose Inhalers

    • Nebulizers

    • Soft Mist Inhaler

    By End-User:

    • Clinic

    • Hospital

    • Home

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Devices for Inhaled Medications Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Devices for Inhaled Medications Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Devices for Inhaled Medications Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Devices for Inhaled Medications Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Devices for Inhaled Medications Market Analysis and Outlook to 2022

    • 7.1 Global Devices for Inhaled Medications Consumption (2017-2022)

    • 7.2 United States Devices for Inhaled Medications Consumption (2017-2022)

    • 7.3 Europe Devices for Inhaled Medications Consumption (2017-2022)

    • 7.4 China Devices for Inhaled Medications Consumption (2017-2022)

    • 7.5 Japan Devices for Inhaled Medications Consumption (2017-2022)

    • 7.6 India Devices for Inhaled Medications Consumption (2017-2022)

    • 7.7 South Korea Devices for Inhaled Medications Consumption (2017-2022)

    8 Region and Country-wise Devices for Inhaled Medications Market Analysis and Outlook to 2028

    • 8.1 Global Devices for Inhaled Medications Consumption Forecast (2022-2028)

    • 8.2 United States Devices for Inhaled Medications Consumption Forecast (2022-2028)

    • 8.3 Europe Devices for Inhaled Medications Consumption Forecast (2022-2028)

    • 8.4 China Devices for Inhaled Medications Consumption Forecast (2022-2028)

    • 8.5 Japan Devices for Inhaled Medications Consumption Forecast (2022-2028)

    • 8.6 India Devices for Inhaled Medications Consumption Forecast (2022-2028)

    • 8.7 South Korea Devices for Inhaled Medications Consumption Forecast (2022-2028)

    9 Global Devices for Inhaled Medications Market Outlook by Types and Applications to 2022

    • 9.1 Global Devices for Inhaled Medications Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Dry Powder Inhalers Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Metered-Dose Inhalers Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Nebulizers Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Soft Mist Inhaler Consumption and Growth Rate (2017-2022)

    • 9.2 Global Devices for Inhaled Medications Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Home Consumption and Growth Rate (2017-2022)

    10 Global Devices for Inhaled Medications Market Outlook by Types and Applications to 2028

    • 10.1 Global Devices for Inhaled Medications Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Dry Powder Inhalers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Metered-Dose Inhalers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Nebulizers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Soft Mist Inhaler Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Devices for Inhaled Medications Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Home Consumption Forecast and Growth Rate (2022-2028)

    11 Global Devices for Inhaled Medications Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Devices for Inhaled Medications Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Devices for Inhaled Medications Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Devices for Inhaled Medications Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Devices for Inhaled Medications Market Competitive Analysis

    • 14.1 Catalent, Inc

      • 14.1.1 Catalent, Inc Company Details

      • 14.1.2 Catalent, Inc Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Catalent, Inc Devices for Inhaled Medications Product and Service

    • 14.2 Mantecorp

      • 14.2.1 Mantecorp Company Details

      • 14.2.2 Mantecorp Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Mantecorp Devices for Inhaled Medications Product and Service

    • 14.3 3M

      • 14.3.1 3M Company Details

      • 14.3.2 3M Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 3M Devices for Inhaled Medications Product and Service

    • 14.4 Qualicaps

      • 14.4.1 Qualicaps Company Details

      • 14.4.2 Qualicaps Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Qualicaps Devices for Inhaled Medications Product and Service

    • 14.5 Boehringer Ingelheim

      • 14.5.1 Boehringer Ingelheim Company Details

      • 14.5.2 Boehringer Ingelheim Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Boehringer Ingelheim Devices for Inhaled Medications Product and Service

    • 14.6 Inhalexper

      • 14.6.1 Inhalexper Company Details

      • 14.6.2 Inhalexper Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Inhalexper Devices for Inhaled Medications Product and Service

    • 14.7 Hovione

      • 14.7.1 Hovione Company Details

      • 14.7.2 Hovione Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Hovione Devices for Inhaled Medications Product and Service

    • 14.8 Aerovance

      • 14.8.1 Aerovance Company Details

      • 14.8.2 Aerovance Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Aerovance Devices for Inhaled Medications Product and Service

    • 14.9 MicroDose Therapeutx

      • 14.9.1 MicroDose Therapeutx Company Details

      • 14.9.2 MicroDose Therapeutx Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 MicroDose Therapeutx Devices for Inhaled Medications Product and Service

    • 14.10 VertMarkets, Inc

      • 14.10.1 VertMarkets, Inc Company Details

      • 14.10.2 VertMarkets, Inc Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 VertMarkets, Inc Devices for Inhaled Medications Product and Service

    • 14.11 GlaxoSmithKline

      • 14.11.1 GlaxoSmithKline Company Details

      • 14.11.2 GlaxoSmithKline Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 GlaxoSmithKline Devices for Inhaled Medications Product and Service

    • 14.12 Consort Medical

      • 14.12.1 Consort Medical Company Details

      • 14.12.2 Consort Medical Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Consort Medical Devices for Inhaled Medications Product and Service

    • 14.13 Cipla

      • 14.13.1 Cipla Company Details

      • 14.13.2 Cipla Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Cipla Devices for Inhaled Medications Product and Service

    • 14.14 AstraZeneca

      • 14.14.1 AstraZeneca Company Details

      • 14.14.2 AstraZeneca Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 AstraZeneca Devices for Inhaled Medications Product and Service

    • 14.15 Novartis

      • 14.15.1 Novartis Company Details

      • 14.15.2 Novartis Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Novartis Devices for Inhaled Medications Product and Service

    • 14.16 Qualicaps

      • 14.16.1 Qualicaps Company Details

      • 14.16.2 Qualicaps Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Qualicaps Devices for Inhaled Medications Product and Service

    • 14.17 Cambridge Consultants

      • 14.17.1 Cambridge Consultants Company Details

      • 14.17.2 Cambridge Consultants Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Cambridge Consultants Devices for Inhaled Medications Product and Service

    • 14.18 Chiesi

      • 14.18.1 Chiesi Company Details

      • 14.18.2 Chiesi Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Chiesi Devices for Inhaled Medications Product and Service

    • 14.19 Meda

      • 14.19.1 Meda Company Details

      • 14.19.2 Meda Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Meda Devices for Inhaled Medications Product and Service

    • 14.20 Civitas/Alkermes

      • 14.20.1 Civitas/Alkermes Company Details

      • 14.20.2 Civitas/Alkermes Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Civitas/Alkermes Devices for Inhaled Medications Product and Service

    • 14.21 Mannkind

      • 14.21.1 Mannkind Company Details

      • 14.21.2 Mannkind Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Mannkind Devices for Inhaled Medications Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Devices for Inhaled Medications

    • Figure Devices for Inhaled Medications Picture

    • Table Global Devices for Inhaled Medications Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Devices for Inhaled Medications Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Devices for Inhaled Medications Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Devices for Inhaled Medications Consumption by Country (2017-2022)

    • Figure United States Devices for Inhaled Medications Consumption and Growth Rate (2017-2022)

    • Table Europe Devices for Inhaled Medications Consumption and Growth Rate (2017-2022)

    • Figure China Devices for Inhaled Medications Consumption and Growth Rate (2017-2022)

    • Figure Japan Devices for Inhaled Medications Consumption and Growth Rate (2017-2022)

    • Figure India Devices for Inhaled Medications Consumption and Growth Rate (2017-2022)

    • Figure South Korea Devices for Inhaled Medications Consumption and Growth Rate (2017-2022)

    • Figure Global Devices for Inhaled Medications Consumption Forecast by Country (2022-2028)

    • Figure United States Devices for Inhaled Medications Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Devices for Inhaled Medications Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Devices for Inhaled Medications Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Devices for Inhaled Medications Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Devices for Inhaled Medications Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Devices for Inhaled Medications Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dry Powder Inhalers Consumption and Growth Rate (2017-2022)

    • Figure Global Metered-Dose Inhalers Consumption and Growth Rate (2017-2022)

    • Figure Global Nebulizers Consumption and Growth Rate (2017-2022)

    • Figure Global Soft Mist Inhaler Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Home Consumption and Growth Rate (2017-2022)

    • Figure Global Dry Powder Inhalers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metered-Dose Inhalers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nebulizers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Soft Mist Inhaler Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Devices for Inhaled Medications Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Devices for Inhaled Medications Export by Region (Top 5 Countries) (2017-2028)

    • Table Catalent, Inc (Foundation Year, Company Profile and etc.)

    • Table Catalent, Inc Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Catalent, Inc Devices for Inhaled Medications Product and Service

    • Table Mantecorp (Foundation Year, Company Profile and etc.)

    • Table Mantecorp Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mantecorp Devices for Inhaled Medications Product and Service

    • Table 3M (Foundation Year, Company Profile and etc.)

    • Table 3M Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M Devices for Inhaled Medications Product and Service

    • Table Qualicaps (Foundation Year, Company Profile and etc.)

    • Table Qualicaps Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qualicaps Devices for Inhaled Medications Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Devices for Inhaled Medications Product and Service

    • Table Inhalexper (Foundation Year, Company Profile and etc.)

    • Table Inhalexper Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inhalexper Devices for Inhaled Medications Product and Service

    • Table Hovione (Foundation Year, Company Profile and etc.)

    • Table Hovione Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hovione Devices for Inhaled Medications Product and Service

    • Table Aerovance (Foundation Year, Company Profile and etc.)

    • Table Aerovance Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aerovance Devices for Inhaled Medications Product and Service

    • Table MicroDose Therapeutx (Foundation Year, Company Profile and etc.)

    • Table MicroDose Therapeutx Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table MicroDose Therapeutx Devices for Inhaled Medications Product and Service

    • Table VertMarkets, Inc (Foundation Year, Company Profile and etc.)

    • Table VertMarkets, Inc Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table VertMarkets, Inc Devices for Inhaled Medications Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Devices for Inhaled Medications Product and Service

    • Table Consort Medical (Foundation Year, Company Profile and etc.)

    • Table Consort Medical Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Consort Medical Devices for Inhaled Medications Product and Service

    • Table Cipla (Foundation Year, Company Profile and etc.)

    • Table Cipla Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Devices for Inhaled Medications Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Devices for Inhaled Medications Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Devices for Inhaled Medications Product and Service

    • Table Qualicaps (Foundation Year, Company Profile and etc.)

    • Table Qualicaps Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qualicaps Devices for Inhaled Medications Product and Service

    • Table Cambridge Consultants (Foundation Year, Company Profile and etc.)

    • Table Cambridge Consultants Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cambridge Consultants Devices for Inhaled Medications Product and Service

    • Table Chiesi (Foundation Year, Company Profile and etc.)

    • Table Chiesi Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiesi Devices for Inhaled Medications Product and Service

    • Table Meda (Foundation Year, Company Profile and etc.)

    • Table Meda Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meda Devices for Inhaled Medications Product and Service

    • Table Civitas/Alkermes (Foundation Year, Company Profile and etc.)

    • Table Civitas/Alkermes Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Civitas/Alkermes Devices for Inhaled Medications Product and Service

    • Table Mannkind (Foundation Year, Company Profile and etc.)

    • Table Mannkind Devices for Inhaled Medications Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mannkind Devices for Inhaled Medications Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US